Last Tuesday, House Speaker Mike Johnson unexpectedly adjourned the U.S. House of Representatives until September. The next day, the S&P 500 SPX hit another all-time high. Coincidence? Several ...

Complete Response Letters recently issued by the FDA signal heightened scrutiny of trial design and reinforce the agency’s shifting regulatory expectations for sponsors and CROs.